🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 NEWS! 8️⃣,2️⃣8️⃣0️⃣ participants have already been randomized in the REBOOT (tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion) trial! 📆 Less than 3️⃣% of the estimated sample size to be recruited 🚀 🎯 Target = 8️⃣,5️⃣0️⃣0️⃣

📣 Christmas NEWS! 🌲 8️⃣,2️⃣9️⃣0️⃣ participants have already been recruited in the REBOOT (tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion) trial! 📆 Less than 3️⃣% of the estimated sample size to be recruited 🚀 🎯 Target = 8️⃣,5️⃣0️⃣0️⃣

8️⃣,2️⃣9️⃣6️⃣ participants have already been recruited in the REBOOT trial! Cardio Son Espases recruited its patient #200 just before the end of the year! 🎯 Target =8️⃣,5️⃣0️⃣0️⃣ Borja Ibanez Xavier Rosselló CNIC Luis Nieto @raul_rasesjd Oriol Rodriguez Manuel Anguita Alessandro Sionis

🎥¿Has visto el último video de CNIC Instituto de Salud Carlos III (ISCIII) Ministerio de Ciencia, Innovación y Universidades ?🌐Te contamos la investigación innovadora que hacemos para combatir al #1 asesino: Enfermedad Cardiovascular🫀💡 Descubre nuestros programas en youtube.com/watch?v=exJTGH… Borja Ibanez European Society of Cardiology SOMM alliance

8️⃣,3️⃣8️⃣1️⃣ participants have already been recruited in the REBOOT (tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion) trial! 📆 Less than 2️⃣% of the estimated sample size to be recruited 🚀 🎯 Target = 8️⃣,5️⃣0️⃣0️⃣

8️⃣,3️⃣9️⃣9️⃣ participants have already been recruited in the REBOOT (tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion) trial! 📆 1️⃣0️⃣1️⃣ patients to go! 🚀 🎯 Target = 8️⃣,5️⃣0️⃣0️⃣

8️⃣,4️⃣2️⃣3️⃣ participants have already been recruited in the REBOOT (tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion) trial! 📆 7️⃣7️⃣ patients to go! 🚀 🎯 Target = 8️⃣,5️⃣0️⃣0️⃣

La noche del sábado 6 de abril se cerrará la plataforma de reclutamiento. Queda por tanto sólo esta semana para poder incluir los últimos pacientes y cruzar la meta! Muchas gracias a tod@s por vuestro grandísimo esfuerzo. Borja Ibanez CNIC JóvenesSEC Xavier Rosselló

A punto de finalizar el reclutamiento del REBOOT trial !! 🚀🚀 Gracias a todos por vuestra implicación y compromiso !! 👏👏 Soc Esp Cardiología Borja Ibanez Xavier Rosselló ResiSEC CNIC … 🔝

ÚLTIMA SEMANA activa para reclutamiento!! vamos!! último esfuerzo!!

📈 encuesta de uso de antiplaquetarios en SCA ‼️ oportunidad de mostrar si las guías de SCA han tenido impacto en vida real. cuantos más participemos, mejor veremos la tendencia de cambio (o no...) questionnaire.aplusaresearch.com/wix/p504862086…

what do you anticipate the results will be? POLL👉

Best wishes on behalf of the REBOOT community!

From @DapaTAVI, we wish you all the best in 2025. We hope to announce the results of @DapaTAVI soon, at the ACC congress. Vamosss Soc Esp Cardiología CNIC ACI-SEC: Hemodinamica Sección Cardiología Geriátrica Asociación Cardiología Clínica SEC JóvenesSEC Sergio Raposeiras-Roubín Borja Ibanez Xavier Rosselló Ignacio J. Amat Muthu Vaduganathan

REBOOT is closing out! We are ensuring that all events are documented, reported, and adequately adjudicated! A big thanks to all local investigators, who are doing their best to minimise losses to follow up. Shortly, we will lock and analyse the dataset!! CNIC

REBOOT trial Xavier Rosselló European Society of Cardiology European Society of Cardiology Journals Jesús Álvarez-García Prof Chris P Gale Javed Butler John Munkhaugen Dan Atar Gregg W. Stone MD rafavidalperez HU Son Espases IdISBa Sergio Raposeiras-Roubín JóvenesSEC CVCT - CardioVascular Clinical Trialists Faiez ZANNAD Harriette Van Spall, MD MPH 🇨🇦 Absolutely! REBOOT trial 8500 patients, BETAMI and DANBLOCK trials together 6000 pt. All post-MI with EF>40%. This year at #ESCcongress2025 in our hometown MADRID this clinical dilemma will be solved once and forever

🏠 Home ❤️